The US Food & Drug Administration (FDA) has approved the first generic version of Truvada (emitricitabine/tenofovir disoproxil fumarate), a medication used in the treatment and prevention of HIV infection. Gilead Science's branded drug Truvada is a combination of the antiretroviral drugs...

A combination therapy used to reduce the chances of HIV infection in adult patients is safe for adolescents, a new study by the National Institutes of Health network suggests. Truvada (tenofovir, emtricitabine) is a single pill combination drug currently approved as a pre-exposure prophylaxis...

The US Food and Drug Administration (FDA) has approved the first once-daily, two-drug single pill treatment for certain patients with human immunodeficiency virus type 1 (HIV-1). Approval for Juluca (dolutegravir and rilpivirine) was granted to ViiV Healthcare, a global specialist in HIV owned by...

Juluca (dolutegravir and rilpivirine), the first two-drug regimen for certain patients with HIV is now available in pharmacies across the United States. In November 2017, Viiv Healthcare, owned by pharmaceutical giant GlaxoSmithKline, gained US Food and Drug Administration (FDA) approval for...

Over the course of 2017, the number of approvals granted by the US Food and Drug Administration (FDA) reached a 21-year high. More than 1,000 generic drugs were approved by the agency, according to FDA Commissioner Scott Gottlieb, MD, while first-time generic drug approvals numbered 74. Novel drug...

Last year was a record-breaking year for generic drug approvals in the United States. The US Food and Drug Administration (FDA) approved 1,027 generic drugs, 843 of which were full approvals, with tentative approvals making up the remainder. Tentative approvals are generic drugs considered ready...

A new treatment option is available for patients with multi-drug resistant (MDR) HIV following the US Food and Drug Administration’s (FDA) approval of Trogarzo (ibalizumab-uiyk). The medication, developed by TaiMed Biologics USA Corp, is a new form of antiretroviral medication indicated for...

Nearly half (49 percent) of all adolescents aged between 13 and 17 were up-to-date with their human papillomavirus (HPV) vaccines in 2017, according to new data from the Centers for Disease Control and Prevention (CDC). The organization’s latest Morbidity and Mortality Weekly Report (MMWR)...